Table 3.
Quintiles [Range] of cis- vaccenic acid (18:1n-7) | Cases | Odds ratio (95% CI) for coronary heart disease
|
|
---|---|---|---|
Model 1* | Model 2† | ||
Q1 (low) [0.90–1.49]‡ | 233 | 1.0 | 1.0 |
Q2 [1.50–1.68] | 191 | 0.76 (0.56–1.02) | 0.75 (0.55–1.03) |
Q3 [1.69–1.92] | 208 | 0.74 (0.54–1.03) | 0.66 (0.47–0.94) |
Q4 [1.93–2.53] | 175 | 0.60 (0.42–0.85) | 0.55 (0.38–0.81) |
Q5 (high) [>2.54] | 193 | 0.59 (0.40–0.88) | 0.56 (0.37–0.85) |
P for trend | 0.01 | 0.007 | |
| |||
Per SD increase of log-vaccenic acid (cis 18:1n-7) | 0.80 (0.70–0.91) | 0.79 (0.69–0.91) |
Model 1 adjusted for matching variables and cis-palmitoleic acid; SD=standard deviation of log-transformed red blood cell membrane cis- palmitoleic acid
Model 2 adjusted for matching variables plus body mass index, prevalent hypertension, hypercholesterolemia, atrial fibrillation, diabetes, left ventricular hypertrophy, smoking, alcohol intake, physical activity, and red blood cell membrane 18:0, 16:0, and marine omega-3 fatty acids (20:5n-3, 22:5n-3, and 22:6n-3)
Fatty acids expressed as percentage of total red blood cell membrane fatty acids